2C-T-8
2C-T-8
A psychedelic phenethylamine of the 2C family
2C-T-8 is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin and is known for its psychoactive effects.
Chemical structure and properties
2C-T-8 is chemically known as 2,5-dimethoxy-4-(n)-propylthiophenethylamine. It belongs to the class of psychedelic compounds known as phenethylamines, which are characterized by a phenyl ring bound to an amino group through an ethyl chain. The presence of a propylthio group at the 4-position of the phenyl ring distinguishes 2C-T-8 from other compounds in the 2C series.
Pharmacology
2C-T-8 acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound's interaction with these receptors leads to alterations in perception, mood, and cognition.
Effects
The effects of 2C-T-8 are similar to those of other psychedelics, such as LSD and psilocybin. Users report visual and auditory hallucinations, altered sense of time, and changes in thought patterns. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Synthesis
2C-T-8 was first synthesized by Alexander Shulgin, a renowned chemist known for his work with psychedelic compounds. The synthesis involves the reaction of 2,5-dimethoxybenzaldehyde with propylthiol, followed by reductive amination with nitroethane and subsequent reduction to yield the final product.
Legal status
The legal status of 2C-T-8 varies by country. In some jurisdictions, it is classified as a controlled substance, making its manufacture, distribution, and possession illegal. In others, it may be unregulated or fall under analogue laws.
Related compounds
2C-T-8 is part of the 2C family of psychedelics, which includes other compounds such as 2C-B, 2C-I, and 2C-T-7. These compounds share a common phenethylamine backbone but differ in their substituents, leading to variations in their pharmacological profiles and effects.
Related pages
Gallery
2C-T-8
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD